Peptron is a pharmaceutical company in south korea. They are developing exenatide (pt320, glp1 receptor agonist, presendin, exendin-4 are all other names for this) but they are developing it for use in parkinsons disease. We are developing it for iih. We have a manufacturing agreement with peptron to buy the formulation from them if we get approved. We have the patents for it in eu uk us au jp in iih, they have exclusive rights for it in sk in iih as well that we gave them, as well as worldwide in parkinsons. Thats the dumbed down version
- Forums
- ASX - By Stock
- IXC
- Questions to ask Tom in relation to recent announcement dated 27.09.2021
Questions to ask Tom in relation to recent announcement dated 27.09.2021, page-84
-
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.0¢ |
Change
-0.002(2.78%) |
Mkt cap ! $5.261M |
Open | High | Low | Value | Volume |
7.0¢ | 7.3¢ | 7.0¢ | $3.658K | 50.82K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 91099 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.5¢ | 37500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 91099 | 0.070 |
1 | 10000 | 0.051 |
1 | 200000 | 0.050 |
1 | 60001 | 0.041 |
2 | 510000 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.075 | 37500 | 1 |
0.077 | 7950 | 1 |
0.078 | 20000 | 1 |
0.080 | 10000 | 1 |
0.081 | 888 | 1 |
Last trade - 15.07pm 26/06/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |